SCHEMBL24286495

SCHEMBL24286495

COc1cc(S(=O)(=O)N2CCOc3ccc(-c4cc(F)cc(F)c4Cl)cc32)ccc1F

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.46
▸ POLB P06746 3/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ RORC P51449 4/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPC1 O15118 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CPT1A P50416 5/20 0.42
▸ CPT1B Q92523 4/20 0.42
▸ CPT2 P23786 3/20 0.42
▸ PKM P14618 1/20 0.39
▸ PKLR P30613 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24286462 0.89 ALDH1A1 (0.47) CYP3A4CYP2D6ALDH1A1POLBMEN1
SCHEMBL24286298 0.89 ALDH1A1 (0.49) CYP3A4CYP2D6ALDH1A1POLBMEN1
SCHEMBL24286809 0.84 CYP2C9 (0.51) CYP3A4CYP2D6ALDH1A1POLBMEN1
SCHEMBL24286256 0.84 CYP3A4 (0.53) CYP3A4CYP2D6ALDH1A1POLBMEN1
SCHEMBL24286304 0.81 NPC1 (0.52) CYP3A4CYP2D6ALDH1A1POLBMEN1
SCHEMBL24286289 0.80 RORC (0.66) RORCPKMPKLR
SCHEMBL24286598 0.80 RORC (0.49) RORCNPC1CPT1ACPT1BCPT2
SCHEMBL24286286 0.77 POLB (0.46) CYP3A4CYP2D6ALDH1A1POLBMEN1
SCHEMBL24286692 0.75 RORC (0.57) RORCCPT1ACPT1BCPT2PKM
SCHEMBL24286265 0.75 RORC (0.49) POLBRORCPKMPKLR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307738-B1 ARYL DIHYDRO-2H-BENZO[B][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE UNIV MICHIGAN REGENTS (US) 2022-04-20 — — EP disclosed
Send feedback